Cerenome, Inc.

CNSY ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $4.3M $76.0K $8.6M $18.1M $18.4M $8.3M $17.6M $5.3M
Accounts Receivable — — — — — $0 $1.2M $178.0K
Inventory — — — — — — $107.0K $107.0K
Total Current Assets $15.2M $5.3M $9.8M $21.8M $19.7M $9.2M $19.8M $9.6M
Property, Plant & Equipment $257.0K $448.0K $906.0K $1.3M $1.5M $1.8M $2.2M $2.3M
Goodwill $372.0K $372.0K $372.0K $372.0K $372.0K $372.0K $372.0K $372.0K
Intangible Assets (Excl. Goodwill) $333.0K $469.0K $42.0K — — — — $6.0M
Total Assets $16.3M $6.6M $11.4M $23.9M $22.0M $12.1M $23.2M $24.0M
Liabilities
Accounts Payable $3.3M $9.5M $4.8M $8.4M $2.6M $789.0K $327.0K $721.0K
Total Current Liabilities $12.3M $15.6M $10.7M $11.9M $5.9M $8.5M $14.5M $17.6M
Long-Term Debt — — — $3.8M $5.0M — — —
Total Liabilities $12.3M $15.6M $12.7M $17.4M $11.1M $9.1M $22.1M $18.8M
Stockholders' Equity
Retained Earnings $-515.9M $-493.5M $-480.5M $-467.2M $-446.9M $-433.5M $-425.3M $-414.4M
Total Stockholders' Equity $4.0M $-8.9M $-1.3M $6.4M $10.8M $3.0M $1.2M $5.2M
← Newer Page 1 of 2 Older →